de Souza Hugo Guedes, Favaro Alvaro, Andrade Alba Livia, Gomes Lenir Yago, Aguiar Simone de Souza, Garcez Mario do Carmo
ANFARMAG Vitoria, Brazil.
Int J Pharm Compd. 2009 Nov-Dec;13(6):532-6.
Influencing the drawing of future legislation, gaining the confidence of consumers, prescribers, and government; and enhancing the communication with the medical profession are among the major upcoming challenges for compounding pharmacists worldwide. In our systematic effort to prevent eror and improve quality, we have learned that guidance is our main ally. When the Brazilian National Health Agency issued legislation that had a major impact on operating costs for compounding businesses, the Brazilian National Health Agency issued legislation that had major impact on operating costs for compounding businesses, the Brazilian National Association of Compounding Pharmacies, a nongovernmental organization, set out to tackle the many deadlocks resulting from the legislation. With the support of compounding pharmacists, the association has been able to develop and implement a National System for the Monitoring and Improvement of Compounding Practices, a process-focused system. Custom-made, individualized drugs are necessary for providing the best treatment, and compounding pharmacies must be viewed and act as partners for health.
影响未来立法的制定、赢得消费者、开处方者和政府的信任以及加强与医学专业人士的沟通，是全球复方药剂师面临的主要挑战。在我们为防止错误和提高质量而进行的系统努力中，我们认识到指南是我们的主要盟友。当巴西国家卫生机构发布对复方业务运营成本有重大影响的立法时，一个非政府组织——巴西复方药剂师全国协会着手解决该立法导致的诸多僵局。在复方药剂师的支持下，该协会得以开发并实施了一个以过程为重点的全国复方操作监测与改进系统。定制的个性化药物对于提供最佳治疗至关重要，复方药房必须被视为健康伙伴并发挥相应作用。
